Ontology type: schema:ScholarlyArticle Open Access: True
2012-06-18
AUTHORSM T Gómez-Casares, E García-Alegria, C E López-Jorge, N Ferrándiz, R Blanco, S Alvarez, J P Vaqué, G Bretones, J M Caraballo, P Sánchez-Bailón, M D Delgado, J Martín-Perez, J C Cigudosa, J León
ABSTRACTChronic myeloid leukemia (CML) progresses from a chronic to a blastic phase where the leukemic cells are proliferative and undifferentiated. The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and dasatinib. In the CML-derived K562 cell line, low concentrations of imatinib induce proliferative arrest and erythroid differentiation. We found that imatinib upregulated the cell cycle inhibitor p27KIP1 (p27) in a time- and -concentration dependent manner, and that the extent of imatinib-mediated differentiation was severely decreased in cells with depleted p27. MYC (c-Myc) is a transcription factor frequently deregulated in human cancer. MYC is overexpressed in untreated CML and is associated to poor response to imatinib. Using K562 sublines with conditional MYC expression (induced by Zn2+ or activated by 4-hydroxy-tamoxifen) we show that MYC prevented the erythroid differentiation induced by imatinib and dasatinib. The differentiation inhibition is not due to increased proliferation of MYC-expressing clones or enhanced apoptosis of differentiated cells. As p27 overexpression is reported to induce erythroid differentiation in K562, we explored the effect of MYC on imatinib-dependent induction of p27. We show that MYC abrogated the imatinib-induced upregulation of p27 concomitantly with the differentiation inhibition, suggesting that MYC inhibits differentiation by antagonizing the imatinib-mediated upregulation of p27. This effect occurs mainly by p27 protein destabilization. This was in part due to MYC-dependent induction of SKP2, a component of the ubiquitin ligase complex that targets p27 for degradation. The results suggest that, although MYC deregulation does not directly confer resistance to imatinib, it might be a factor that contributes to progression of CML through the inhibition of differentiation. More... »
PAGES2239-2246
http://scigraph.springernature.com/pub.10.1038/onc.2012.246
DOIhttp://dx.doi.org/10.1038/onc.2012.246
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1018679426
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/22710719
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Benzamides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Differentiation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Proliferation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclin-Dependent Kinase Inhibitor p27",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dasatinib",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Down-Regulation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Erythroid Cells",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression Regulation, Leukemic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Imatinib Mesylate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Piperazines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins c-myc",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pyrimidines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "S-Phase Kinase-Associated Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Thiazoles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "beta-Globins",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Servicio de Hematolog\u00eda and Unidad de Investigaci\u00f3n, Hospital Universitario Dr Negr\u00edn, Las Palmas, Spain",
"id": "http://www.grid.ac/institutes/grid.411250.3",
"name": [
"Servicio de Hematolog\u00eda and Unidad de Investigaci\u00f3n, Hospital Universitario Dr Negr\u00edn, Las Palmas, Spain"
],
"type": "Organization"
},
"familyName": "G\u00f3mez-Casares",
"givenName": "M T",
"id": "sg:person.0716710447.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716710447.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Garc\u00eda-Alegria",
"givenName": "E",
"id": "sg:person.01315575117.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315575117.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Servicio de Hematolog\u00eda and Unidad de Investigaci\u00f3n, Hospital Universitario Dr Negr\u00edn, Las Palmas, Spain",
"id": "http://www.grid.ac/institutes/grid.411250.3",
"name": [
"Servicio de Hematolog\u00eda and Unidad de Investigaci\u00f3n, Hospital Universitario Dr Negr\u00edn, Las Palmas, Spain"
],
"type": "Organization"
},
"familyName": "L\u00f3pez-Jorge",
"givenName": "C E",
"id": "sg:person.0741260437.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741260437.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "5Current address: MRC Clinical Sciences Centre, Imperial College Faculty of Medicine Hammersmith Hospital Campus, London, UK",
"id": "http://www.grid.ac/institutes/grid.7445.2",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"5Current address: MRC Clinical Sciences Centre, Imperial College Faculty of Medicine Hammersmith Hospital Campus, London, UK"
],
"type": "Organization"
},
"familyName": "Ferr\u00e1ndiz",
"givenName": "N",
"id": "sg:person.0747721140.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747721140.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Blanco",
"givenName": "R",
"id": "sg:person.01232657701.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232657701.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain",
"id": "http://www.grid.ac/institutes/grid.7719.8",
"name": [
"Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain"
],
"type": "Organization"
},
"familyName": "Alvarez",
"givenName": "S",
"id": "sg:person.01310764275.35",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310764275.35"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "5Current address: MRC Clinical Sciences Centre, Imperial College Faculty of Medicine Hammersmith Hospital Campus, London, UK",
"id": "http://www.grid.ac/institutes/grid.7445.2",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"5Current address: MRC Clinical Sciences Centre, Imperial College Faculty of Medicine Hammersmith Hospital Campus, London, UK"
],
"type": "Organization"
},
"familyName": "Vaqu\u00e9",
"givenName": "J P",
"id": "sg:person.01214634161.72",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214634161.72"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Bretones",
"givenName": "G",
"id": "sg:person.01127012261.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127012261.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Caraballo",
"givenName": "J M",
"id": "sg:person.0630222061.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630222061.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Instituto de Investigaciones Biom\u00e9dicas Alberto Sols, CSIC, Madrid, Spain",
"id": "http://www.grid.ac/institutes/grid.466793.9",
"name": [
"Instituto de Investigaciones Biom\u00e9dicas Alberto Sols, CSIC, Madrid, Spain"
],
"type": "Organization"
},
"familyName": "S\u00e1nchez-Bail\u00f3n",
"givenName": "P",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Delgado",
"givenName": "M D",
"id": "sg:person.015565003621.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015565003621.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Instituto de Investigaciones Biom\u00e9dicas Alberto Sols, CSIC, Madrid, Spain",
"id": "http://www.grid.ac/institutes/grid.466793.9",
"name": [
"Instituto de Investigaciones Biom\u00e9dicas Alberto Sols, CSIC, Madrid, Spain"
],
"type": "Organization"
},
"familyName": "Mart\u00edn-Perez",
"givenName": "J",
"id": "sg:person.01045213643.39",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045213643.39"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain",
"id": "http://www.grid.ac/institutes/grid.7719.8",
"name": [
"Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO), Madrid, Spain"
],
"type": "Organization"
},
"familyName": "Cigudosa",
"givenName": "J C",
"id": "sg:person.01246512175.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246512175.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain",
"id": "http://www.grid.ac/institutes/grid.507090.b",
"name": [
"Departamento de Biolog\u00eda Molecular, Group of Transcriptional Control and Cancer, Facultad de Medicina, Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Universidad de Cantabria-CSIC-SODERCAN, Santander, Spain"
],
"type": "Organization"
},
"familyName": "Le\u00f3n",
"givenName": "J",
"id": "sg:person.01225114153.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225114153.51"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/12013",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047410274",
"https://doi.org/10.1038/12013"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc2147",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029023662",
"https://doi.org/10.1038/nrc2147"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1202746",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050186337",
"https://doi.org/10.1038/sj.onc.1202746"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc1567",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046456325",
"https://doi.org/10.1038/nrc1567"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc2347",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046912140",
"https://doi.org/10.1038/nrc2347"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc2368",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020611190",
"https://doi.org/10.1038/nrc2368"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/12027",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033906773",
"https://doi.org/10.1038/12027"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc2231",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017741214",
"https://doi.org/10.1038/nrc2231"
],
"type": "CreativeWork"
}
],
"datePublished": "2012-06-18",
"datePublishedReg": "2012-06-18",
"description": "Chronic myeloid leukemia (CML) progresses from a chronic to a blastic phase where the leukemic cells are proliferative and undifferentiated. The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and dasatinib. In the CML-derived K562 cell line, low concentrations of imatinib induce proliferative arrest and erythroid differentiation. We found that imatinib upregulated the cell cycle inhibitor p27KIP1 (p27) in a time- and -concentration dependent manner, and that the extent of imatinib-mediated differentiation was severely decreased in cells with depleted p27. MYC (c-Myc) is a transcription factor frequently deregulated in human cancer. MYC is overexpressed in untreated CML and is associated to poor response to imatinib. Using K562 sublines with conditional MYC expression (induced by Zn2+ or activated by 4-hydroxy-tamoxifen) we show that MYC prevented the erythroid differentiation induced by imatinib and dasatinib. The differentiation inhibition is not due to increased proliferation of MYC-expressing clones or enhanced apoptosis of differentiated cells. As p27 overexpression is reported to induce erythroid differentiation in K562, we explored the effect of MYC on imatinib-dependent induction of p27. We show that MYC abrogated the imatinib-induced upregulation of p27 concomitantly with the differentiation inhibition, suggesting that MYC inhibits differentiation by antagonizing the imatinib-mediated upregulation of p27. This effect occurs mainly by p27 protein destabilization. This was in part due to MYC-dependent induction of SKP2, a component of the ubiquitin ligase complex that targets p27 for degradation. The results suggest that, although MYC deregulation does not directly confer resistance to imatinib, it might be a factor that contributes to progression of CML through the inhibition of differentiation.",
"genre": "article",
"id": "sg:pub.10.1038/onc.2012.246",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1097543",
"issn": [
"0950-9232",
"1476-5594"
],
"name": "Oncogene",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "17",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "32"
}
],
"keywords": [
"chronic myeloid leukemia",
"untreated chronic myeloid leukemia",
"progression of CML",
"CML-derived K562 cell line",
"chronic myeloid leukemia cells",
"downregulation of p27Kip1",
"differentiation inhibition",
"cell cycle inhibitor p27Kip1",
"BCR-ABL kinase inhibitors",
"conditional MYC expression",
"myeloid leukemia cells",
"erythroid differentiation",
"concentration-dependent manner",
"blastic phase",
"poor response",
"proliferation of MYC",
"myeloid leukemia",
"leukemic cells",
"imatinib",
"inhibition of differentiation",
"K562 sublines",
"kinase inhibitors",
"K562 cell line",
"leukemia cells",
"human cancers",
"p27 overexpression",
"p27",
"MYC expression",
"MYC deregulation",
"dependent manner",
"effect of Myc",
"cell lines",
"dasatinib",
"inhibition",
"upregulation",
"MYC",
"p27Kip1",
"proliferative arrest",
"cells",
"differentiated cells",
"induction",
"differentiation",
"chronic",
"transcription factors",
"leukemia",
"cancer",
"progression",
"low concentrations",
"downregulation",
"factors",
"ubiquitin ligase",
"arrest",
"sublines",
"apoptosis",
"inhibitors",
"Skp2",
"proliferation",
"K562",
"overexpression",
"effect",
"expression",
"response",
"clones",
"protein destabilization",
"deregulation",
"resistance",
"concentration",
"manner",
"extent",
"lines",
"ligase",
"time",
"results",
"part",
"components",
"destabilization",
"phase",
"degradation"
],
"name": "MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1",
"pagination": "2239-2246",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1018679426"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/onc.2012.246"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"22710719"
]
}
],
"sameAs": [
"https://doi.org/10.1038/onc.2012.246",
"https://app.dimensions.ai/details/publication/pub.1018679426"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:28",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_567.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/onc.2012.246"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2012.246'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2012.246'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2012.246'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2012.246'
This table displays all metadata directly associated to this object as RDF triples.
355 TRIPLES
22 PREDICATES
132 URIs
116 LITERALS
27 BLANK NODES